138 related articles for article (PubMed ID: 34954294)
1. American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell Therapy.
Jain T; Knight T; Alencar MC; Davis L; Rao K; Im A; Malone AK;
Transplant Cell Ther; 2022 Mar; 28(3):125-133. PubMed ID: 34954294
[TBL] [Abstract][Full Text] [Related]
2. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.
Kanate AS; Majhail NS; Savani BN; Bredeson C; Champlin RE; Crawford S; Giralt SA; LeMaistre CF; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Veys PA; Carpenter PA; Hamadani M
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1247-1256. PubMed ID: 32165328
[TBL] [Abstract][Full Text] [Related]
3. American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell Transplantation.
Khan S; Juckett MB; Komanduri KV; Krishnan A; Burns LJ;
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1322-8. PubMed ID: 22522027
[TBL] [Abstract][Full Text] [Related]
4. Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation.
Mohty M; Duarte RF; Kuball J; Bader P; Basak GW; Bonini C; Carreras E; Chabannon C; Dufour C; Gennery A; Lankester A; Lanza F; Ljungman P; Montoto S; Nagler A; Snowden JA; Styczynski J; Sureda A; Kröger N
Bone Marrow Transplant; 2018 Dec; 53(12):1548-1552. PubMed ID: 29720705
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Shah N; Callander N; Ganguly S; Gul Z; Hamadani M; Costa L; Sengsayadeth S; Abidi M; Hari P; Mohty M; Chen YB; Koreth J; Landau H; Lazarus H; Leather H; Majhail N; Nath R; Osman K; Perales MA; Schriber J; Shaughnessy P; Vesole D; Vij R; Wingard J; Giralt S; Savani BN;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1155-66. PubMed ID: 25769794
[TBL] [Abstract][Full Text] [Related]
6. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
[TBL] [Abstract][Full Text] [Related]
7. Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy.
Kanate AS; Majhail N; DeFilipp Z; Dhakal B; Dholaria B; Hamilton B; Herrera AF; Inamoto Y; Jain T; Perales MA; Carpenter PA; Hamadani M
Transplant Cell Ther; 2023 Oct; 29(10):594-597. PubMed ID: 37422194
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative.
Auletta JJ; Khera N; DeMartino P; Kelkar AH; Yusuf RA; Davies SM; Knutson J; Beaver E; Maloney A; Majhail NS
Transplant Cell Ther; 2023 Nov; 29(11):713-720. PubMed ID: 37579920
[TBL] [Abstract][Full Text] [Related]
10. Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in Canada.
Lachance S; Gomes MM; Bambace NM; Bittencourt H; Lepic K; Shafey M; Karpinski J; Guilcher GMT
Transplant Cell Ther; 2021 Sep; 27(9):702-706. PubMed ID: 34153503
[TBL] [Abstract][Full Text] [Related]
11. Quo vadis, my transplant fellow: a discussion of transplant surgery fellowship training activity in the United States and Canada: 1991-1997. Education Committee of the American Society of Transplant Surgeons.
Kaufman DB; Ascher NL
Transplantation; 1998 Jan; 65(2):269-72. PubMed ID: 9458028
[TBL] [Abstract][Full Text] [Related]
12. Program requirements for residency/fellowship education in neuroendovascular surgery/interventional neuroradiology: special report on graduate medical education: a joint statement by the American Society of Interventional and Therapeutic Neuroradiology, Congress of Neurological Surgeons and American Association of Neurological Surgeons, American Society of Neuroradiology.
Neurosurgery; 2000 Jun; 46(6):1486-93; discussion 1494-7. PubMed ID: 10834652
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence Approaches in Hematopoietic Cell Transplantation: A Review of the Current Status and Future Directions.
Muhsen IN; ElHassan T; Hashmi SK
Turk J Haematol; 2018 Aug; 35(3):152-157. PubMed ID: 29880463
[TBL] [Abstract][Full Text] [Related]
14. A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help.
Curran KJ; Nikiforow S; Bachier C; Hsu YM; Maloney D; Maus MV; McCarthy P; Porter D; Shi P; Shpall EJ; William B; Wacker K; Warkentin P; Heslop HE
Blood Adv; 2024 Feb; 8(4):1053-1061. PubMed ID: 37467016
[TBL] [Abstract][Full Text] [Related]
15. Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation in Children.
de Koning C; Plantinga M; Besseling P; Boelens JJ; Nierkens S
Biol Blood Marrow Transplant; 2016 Feb; 22(2):195-206. PubMed ID: 26341398
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a cell processing laboratory to support hematopoietic stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy.
Mukherjee S; Reddy O; Panch S; Stroncek D
Transfus Apher Sci; 2021 Feb; 60(1):103066. PubMed ID: 33472742
[TBL] [Abstract][Full Text] [Related]
17. Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.
Palmer J; McCune JS; Perales MA; Marks D; Bubalo J; Mohty M; Wingard JR; Paci A; Hassan M; Bredeson C; Pidala J; Shah N; Shaughnessy P; Majhail N; Schriber J; Savani BN; Carpenter PA
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1915-1925. PubMed ID: 27481448
[TBL] [Abstract][Full Text] [Related]
18. Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program.
Dulan SO; Viers KL; Wagner JR; Clark MC; Chang B; Gorospe GL; Londrc A; Brown AS; Rosenthal J; Smith EP; Forman SJ; Snyder DS; Budde LE
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1386-1393. PubMed ID: 32439475
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Gomez-Arteaga A; Gyurkocza B
Curr Opin Hematol; 2020 Mar; 27(2):115-121. PubMed ID: 31913152
[TBL] [Abstract][Full Text] [Related]
20. Innate Immune Recovery Predicts CD4
de Koning C; Langenhorst J; van Kesteren C; Lindemans CA; Huitema ADR; Nierkens S; Boelens JJ
Biol Blood Marrow Transplant; 2019 Apr; 25(4):819-826. PubMed ID: 30359735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
